Evidence map›Paper›PMID 41199746›Full record

ArticleFrontiers in genetics2025

aiGeneR 3.0: an enhanced deep network model for resistant strain identification and multi-drug resistance prediction in

Debasish Swapnesh Kumar Nayak, Abhilash Pati, Amrutanshu Panigrahi, Mudassir Khan, Bayan Alabdullah, Santanu Kumar Sahoo, Bibhuprasad Sahu, Abrar Almjally, Saurav Mallik, Tripti Swarnkar

Abstract read
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Debasish Swapnesh Kumar NayakDepartment of Computer Science & Engineering, Siksha "O" Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
Abhilash PatiDepartment of Computer Science & Engineering, Siksha "O" Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
Amrutanshu PanigrahiDepartment of Computer Science & Engineering, Siksha "O" Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
Mudassir KhanDepartment of Computer Science, College of Computer Science, Applied College Tanumah, King Khalid University, Abha, Saudi Arabia.
Bayan AlabdullahDepartment of Information Systems, College of Computer and Information Sciences, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Santanu Kumar SahooDepartment of Electronics and Communication Engineering, Siksha "O" Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
Bibhuprasad SahuSymbiosis Institute of Technology, Hyderabad Campus, Symbiosis International University, Pune, India.
Abrar AlmjallyCollege of Computer and Information Sciences, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Saurav MallikDepartment of Environmental Health, Harvard T H Chan School of Public Health, Boston, MA, United States.
Tripti SwarnkarDepartment of Computer Application, National Institute of Technology, Raipur, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Infectious diseases pose a global health threat, with antimicrobial resistance (AMR) exacerbating the issue. Considering Objective: Machine learning (ML), particularly deep learning (DL), has proven effective in rapidly detecting strains for infection prevention and reducing mortality rates. We proposed aiGeneR 3.0, a simplified and effective DL model employing a long-short-term memory mechanism for identifying multi-drug resistant and resistant strains in Results: Our aiGeneR 3.0 can handle imbalances and small datasets, offering higher classification accuracy (93%) with a simple model architecture. The multi-drug resistance prediction ability of aiGeneR 3.0 has a prediction accuracy of 98%. aiGeneR 3.0 uses deep networks (LSTM) with next-generation sequencing (NGS) data, making it suitable for novel antibiotics and growing resistance identification in the future. Conclusion: This work uniquely integrates SNP-level insights with DL, offering potential clinical utility in guiding antibiotic stewardship. It also enables a robust, generalized, and memorized model for future use in AMR analysis.

Indexed as

antibiotic resistance genesantimicrobial resistancedeep learningmachine learningnext-generation sequencing

Identifiers

PMID41199746
PMCPMC12588577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.